Table_1.xls (9.5 kB)
Download file

Clinical characteristics of study subjects.

Download (0 kB)
dataset
posted on 19.02.2013, 18:58 by He Huang, Yujie Li, Jihong Liu, Minghui Zheng, Yanling Feng, Kunhua Hu, Yongwen Huang, Qidan Huang
*

Resistance: intrinsically chemoresistant tumors were defined as those with persistent or recurrent disease within 6 months after the initiation of first-line platinum-based combination chemotherapy. Sensitive: chemosensitive tumors were classified as those with a complete response to chemotherapy and a platinum-free interval of >6 months.

**

Paclitaxel was changed to doxepaclitaxel due to grade III neurotoxicity.

***

Carboplatin was changed to cisplatin due to grade III neutropenia.

History